cymbalta - Drivetime Radio

System Organ Class /Adverse ReactionPercentage of Patients Reporting ReactionCymbalta Cymbalta60 mg once 60 mg twicedaily daily(N=228) (N=225)Cymbalta20 mg oncedaily(N=115)Placebo(N=223)Nervous System DisordersSomnolence 7 15 21 5Headache 13 13 15 10Dizziness 6 14 17 6Tremor 0 1 5 0Psychiatric DisordersInsomnia 9 8 13 7Renal and Urinary DisordersPolyuria 3 1 5 2Reproductive System and BreastDisordersErectile dysfunction 1 0 1 4 0Respiratory, Thoracic andMediastinalDisordersCough 6 3 5 4Pharyngolaryngeal pain 3 1 6 1Skin and SubcutaneousTissue DisordersHyperhidrosis 6 6 8 21 Male patients only.The following additional adverse events were reported during placebo-controlled clinicaltrials of duloxetine for MDD or other indications in 8504 patients. Very common eventsare defined as those occurring in ≥10% of patients, common events are defined as thoseoccurring in ≥1% and